Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Brain Neoplasms 41Carcinoma, Non-Small-Cell Lung 35Neoplasm Metastasis 32Pancreatic Neoplasms 30Prostatic Neoplasms 24Lung Neoplasms 21Carcinoma, Hepatocellular 21Melanoma 16Breast Neoplasms 12Liver Neoplasms 10Glioblastoma 10Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Renal Cell 8Neoplasms 7Head and Neck Neoplasms 7Kidney Neoplasms 6Gliosarcoma 6Sarcoma 5Glioma 5Central Nervous System Neoplasms 5Uterine Cervical Neoplasms 4Salivary Gland Neoplasms 4Colorectal Neoplasms 4Vulvar Neoplasms 3Vaginal Neoplasms 3Recurrence 3Radiation Injuries 3Pain 3Ovarian Neoplasms 3Fallopian Tube Neoplasms 3

Interventions

pembrolizumab 6Nivolumab 6Ipilimumab 4Radiotherapy 3talimogene laherparepvec 2budigalimab 2avelumab 2atezolizumab 2Everolimus 2Cyclophosphamide 2zimberelimab 1venetoclax 1vatalanib 1tremelimumab 1temsirolimus 1sapanisertib 1rovalpituzumab tesirine 1poly ICLC 1oblimersen 1lorvotuzumab mertansine 1lanreotide 1glucopyranosyl lipid-A 1fludarabine 1durvalumab 1domatinostat 1cixutumumab 1cemiplimab 1aldesleukin 1Vinorelbine 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Merkel Cell × Radiosurgery × Clear all
NCT03304639 2026-05-13

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

National Cancer Institute (NCI)

Phase 2 Completed
9 enrolled 11 charts
Dermatologic

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡